Biosynth

Biosynth is a long-established, privately-held supplier of fine chemicals and biochemicals for research and pharmaceutical development. Based in Staad, Netherlands, the company has built a reputation over four decades as a provider of high-quality, specialized molecules and custom synthesis services, acting as an enabler for biotech and pharma R&D. Its business model is service-oriented, generating revenue through the sale of catalog products and bespoke manufacturing contracts. While not a therapeutic developer itself, Biosynth occupies a vital niche in the biotech supply chain, supporting innovation across multiple therapeutic areas.

Advanced chemical and biochemical synthesis, fermentation, and purification capabilities for producing fine chemicals, biochemicals, and custom molecules.

Biosynth competes in a fragmented market with large players like Merck KGaA (Sigma-Aldrich), Thermo Fisher Scientific, and Cayman Chemical, as well as numerous smaller specialty manufacturers. Differentiation is achieved through niche expertise, high-quality custom synthesis, and a broad catalog of rare chemicals.